<b> Care plan for HIV+ patients in specialized Aids centers inBrazil: Pharmacotherapeutic form and pilot study </b>

http://dx.doi.org/10.4025/actascihealthsci.v36i1.13184 The objective of this study is to describe a pharmacotherapy form model to monitor patients’ pharmacotherapeutic follow-up (PF) on antiretroviral therapy in a specialized center of Ceará, Brazil. Description comprises its structure up to applica...

Full description

Bibliographic Details
Main Authors: Henry Pablo Lopes Campos e Reis, Karla do Nascimento Magalhães, Catarine Vitor Loureiro, Cristiane Policarpo Carmo, Ângela Maria de Souza Ponciano, Marta Maria de França Fonteles
Format: Article
Language:English
Published: Universidade Estadual de Maringá 2014-03-01
Series:Acta Scientiarum. Health Sciences
Subjects:
HIV
Online Access:http://186.233.154.254/ojs/index.php/ActaSciHealthSci/article/view/13184
id doaj-a27b48d4f8f5423f97b21c5475182990
record_format Article
spelling doaj-a27b48d4f8f5423f97b21c54751829902021-06-02T05:47:02ZengUniversidade Estadual de MaringáActa Scientiarum. Health Sciences1679-92911807-86482014-03-01361919610.4025/actascihealthsci.v36i1.1318410336<b> Care plan for HIV+ patients in specialized Aids centers inBrazil: Pharmacotherapeutic form and pilot study </b>Henry Pablo Lopes Campos e Reis0Karla do Nascimento Magalhães1Catarine Vitor Loureiro2Cristiane Policarpo Carmo3Ângela Maria de Souza Ponciano4Marta Maria de França Fonteles5Universidade Federal do CearáUniversidade Federal do Ceará / Centro de Especialidades Médicas José de AlencarUniversidade Federal do CearáCentro de Especialidades Médicas José de AlencarUniversidade Federal do CearáUniversidade Federal do Cearáhttp://dx.doi.org/10.4025/actascihealthsci.v36i1.13184 The objective of this study is to describe a pharmacotherapy form model to monitor patients’ pharmacotherapeutic follow-up (PF) on antiretroviral therapy in a specialized center of Ceará, Brazil. Description comprises its structure up to application. The preparation and application of the PF registration model were carried out by means of a focal group. The following steps were used for the draft: 1. Review of the literature; 2. Diagnosis of place where pharmaceutical care was undertaken; 3. Choice of the PF method; 4. Selection of clinical indicators; 5. Evaluation by a committee of experts; 6. Development of a standard functional procedure with timetable and evaluation frequency of the tool’s different sections or blocks. 7. Pilot study for evaluation of the form with 25 patients. PF form featured six sections comprising patient’s personal data, pharmaceutical anamnesis and records of adherence evaluation, etc. The description and format of the sections are presented in current essay. Further, 322 issues related to antiretroviral drugs were reported during form filling. The multi-section PF form seemed appropriate and applicable for the report of issues related to antiretroviral drugs in HIV positive patients. It was also a helpful guide for pharmaceutical interventions by a multiprofessional team in specialized healthcare settings.http://186.233.154.254/ojs/index.php/ActaSciHealthSci/article/view/13184documentationHIVpharmaceutical care
collection DOAJ
language English
format Article
sources DOAJ
author Henry Pablo Lopes Campos e Reis
Karla do Nascimento Magalhães
Catarine Vitor Loureiro
Cristiane Policarpo Carmo
Ângela Maria de Souza Ponciano
Marta Maria de França Fonteles
spellingShingle Henry Pablo Lopes Campos e Reis
Karla do Nascimento Magalhães
Catarine Vitor Loureiro
Cristiane Policarpo Carmo
Ângela Maria de Souza Ponciano
Marta Maria de França Fonteles
<b> Care plan for HIV+ patients in specialized Aids centers inBrazil: Pharmacotherapeutic form and pilot study </b>
Acta Scientiarum. Health Sciences
documentation
HIV
pharmaceutical care
author_facet Henry Pablo Lopes Campos e Reis
Karla do Nascimento Magalhães
Catarine Vitor Loureiro
Cristiane Policarpo Carmo
Ângela Maria de Souza Ponciano
Marta Maria de França Fonteles
author_sort Henry Pablo Lopes Campos e Reis
title <b> Care plan for HIV+ patients in specialized Aids centers inBrazil: Pharmacotherapeutic form and pilot study </b>
title_short <b> Care plan for HIV+ patients in specialized Aids centers inBrazil: Pharmacotherapeutic form and pilot study </b>
title_full <b> Care plan for HIV+ patients in specialized Aids centers inBrazil: Pharmacotherapeutic form and pilot study </b>
title_fullStr <b> Care plan for HIV+ patients in specialized Aids centers inBrazil: Pharmacotherapeutic form and pilot study </b>
title_full_unstemmed <b> Care plan for HIV+ patients in specialized Aids centers inBrazil: Pharmacotherapeutic form and pilot study </b>
title_sort <b> care plan for hiv+ patients in specialized aids centers inbrazil: pharmacotherapeutic form and pilot study </b>
publisher Universidade Estadual de Maringá
series Acta Scientiarum. Health Sciences
issn 1679-9291
1807-8648
publishDate 2014-03-01
description http://dx.doi.org/10.4025/actascihealthsci.v36i1.13184 The objective of this study is to describe a pharmacotherapy form model to monitor patients’ pharmacotherapeutic follow-up (PF) on antiretroviral therapy in a specialized center of Ceará, Brazil. Description comprises its structure up to application. The preparation and application of the PF registration model were carried out by means of a focal group. The following steps were used for the draft: 1. Review of the literature; 2. Diagnosis of place where pharmaceutical care was undertaken; 3. Choice of the PF method; 4. Selection of clinical indicators; 5. Evaluation by a committee of experts; 6. Development of a standard functional procedure with timetable and evaluation frequency of the tool’s different sections or blocks. 7. Pilot study for evaluation of the form with 25 patients. PF form featured six sections comprising patient’s personal data, pharmaceutical anamnesis and records of adherence evaluation, etc. The description and format of the sections are presented in current essay. Further, 322 issues related to antiretroviral drugs were reported during form filling. The multi-section PF form seemed appropriate and applicable for the report of issues related to antiretroviral drugs in HIV positive patients. It was also a helpful guide for pharmaceutical interventions by a multiprofessional team in specialized healthcare settings.
topic documentation
HIV
pharmaceutical care
url http://186.233.154.254/ojs/index.php/ActaSciHealthSci/article/view/13184
work_keys_str_mv AT henrypablolopescamposereis bcareplanforhivpatientsinspecializedaidscentersinbrazilpharmacotherapeuticformandpilotstudyb
AT karladonascimentomagalhaes bcareplanforhivpatientsinspecializedaidscentersinbrazilpharmacotherapeuticformandpilotstudyb
AT catarinevitorloureiro bcareplanforhivpatientsinspecializedaidscentersinbrazilpharmacotherapeuticformandpilotstudyb
AT cristianepolicarpocarmo bcareplanforhivpatientsinspecializedaidscentersinbrazilpharmacotherapeuticformandpilotstudyb
AT angelamariadesouzaponciano bcareplanforhivpatientsinspecializedaidscentersinbrazilpharmacotherapeuticformandpilotstudyb
AT martamariadefrancafonteles bcareplanforhivpatientsinspecializedaidscentersinbrazilpharmacotherapeuticformandpilotstudyb
_version_ 1721407963257634816